Resume forDr. Abdulaziz Saddique

B.S. (Pharm.), Pharm.D., CPHQ, SSMBB Personal Data and Education:Personale Data

Marital Status: Married with Four childrenAddress: P.O. Box, 59466Riyadh, 11525 Saudi ArabiaE-mail: azizsaddique@gmail.com

Education

➢ Certified KPI Professional and Practitioner, KPI Institute 2014

➢ Certified Six Sigma Black Belt and Master Black Belt, 2005, QualityAssociates International and ASQ

➢ Certified Professional Healthcare Quality (CPHQ) , Healthcare QualityCertification Board, California, USA 2002

➢ Researches leave The Queen’s University of Belfast Sept. 1987-Jan.1988,conducted research on the Pharmacokinetics of drugs in Patientsundergoing Cardiopulmonary bypass surgery.

➢ Clinical Pharmacy Fellowship 1981-1982 Critical Care and CardiacSurgery Research, United Hospital, and University of Minnesota

➢ Clinical Toxicology Board Certification July 1980 - July 1981 HennepinCounty Poison Center and the University of Minnesota. Minneapolis,Minnesota, USA

➢ Attended the Clinical Scientist Program, Pharmacy Administration,completed 105 Credit hour. University of Minnesota, 1982-83. Programwas not completed because of return to Saudi Arabia

➢ Doctor of Pharmacy University of Minnesota 1980, Minneapolis,Minnesota, USA

➢ Bachelor of Science "Pharmacy" University of Riyadh 1976, Riyadh,Saudi Arabia.

Professional Experience:

➢ Patient’s Integration Project Manager and Administration Consultant, King

Khalid Eye Specialist Hospital, June 2014- May 2015

➢ Executive Director for Quality Management Nov. 1996-2009 King SaudUniversity Hospitals, and College of Medicine. Responsible for the development of a Quality Management program for the

University Hospitals and the College of Medicine. The program will qualify thehospitals to JCAHO accreditation. The program is set to be executed in fourstages:

1. Supervising the Accreditation Process of the Canadian Counsel onHealthcare Accreditation for the University Hospitals, 2007-2010

2. Development of Healthcare Standards for the University Hospitalsbased on JCAHO.

3. Development an updated Clinical Bylaws

4. Development and update of the current hospitals policy andprocedures

5. Development of healthcare Indicators for the university Hospitals

6. Implementation of Quality Management program in accordance toQM System the proposed time frame for this program is two years.

➢ President of Riyadh Quality Management Network March 2000 to 2003

➢ Vice President of Riyadh Quality Management Network, March 1998- March 2000

➢ Director of Pharmacy Services May 1985 - Nov. 1996, King Saud UniversityHospitals, Riyadh, Saudi Arabia. Kind Khalid University Hospital, Riyadh, Saudi Arabia, 950 Beds & King AbdulazizUniversity Hospital, Riyadh, Saudi Arabia, 250 Beds.As a Director of the Pharmacy Services for the University Hospitals my mainresponsibilities were, to develop state of the art pharmacy services, and to overseethe whole operations of the pharmaceutical services.

I have established the following Services during my term:⇒ Full Unit Dose System

⇒ Full I.V. Additives, Cytotoxic compounding and TPN services

⇒ Extemporaneous and Prepackaging Service

⇒ Established the first Hospital based Drug and Poison InformationCenter, 24 hrs Service *

⇒ Clinical Pharmacokinetics Service

⇒ Clinical Pharmacy Service hospital-wide

⇒ Residency program for newly graduated Pharm.D. for one year andfor B.Sc. graduates for two or more years.

⇒ In-service education for pharmacy employees.

⇒ I.V. Nursing team

⇒ Decentralized Pharmacists (Ward Pharmacists)

⇒ Outpatient Pharmacy services ( 9 outpatient pharmacies)

⇒ DUE Program (utilizing CQI approach)

⇒ Implemented Total Quality Management as the Management systemfor the Pharmacy Services

➢ Member of the Central Board for Accreditation of Healthcare Institutions, 2005-Presento Main responsibility was to set the standards of care along with other board

members which was completed in 2008.o Setting up the policies and procedures for the Board

o Examiner for the potential Surveyors interviewed more than 200 applicants.

➢ Member of the Standards Committee, Ministry of Health, 2002- 2006

➢ Member of the Saudi National Quality Management committee 2000.-2003

➢ Member of King Abdulaziz Quality Award 2002- 2009o Member of the general committee which sat the standard for the

Award

➢ Chairman of sectors committee, sub-committee of the Saudi National QualityManagement Committee, 2000-2003

➢ Member of the “National Committee on Pharmaceutical Claims” 2000-2007

➢ Clinical Pharmacist 1983- 2009, Critical Care Units, King Khalid UniversityHospital

➢ Member of the Drug Registration Committee 1989-93 Ministry of Health,Saudi Arabia

➢ Chairman of the Generics registration Committee 1990, Ministry of Health,Saudi Arabia

➢ Assistant Editor, Drug and Poison Information. 1986 – 2009, Micromedex Inc.,Colorado, USA,

➢ Founded the first Saudi Pharmacy Club, 1985The club organized more than 12 Symposia, and conducted monthly meeting

for continuing education in pharmacy, until the Saudi Pharmaceutical Society wasformed in 1988

➢ Vice President: Saudi Pharmaceutical Society 1988-1990

➢ Participate in the development of the new pharmacist's appointment andpromotional scale in collaboration with the office of Civil Services.

➢ Chairman, Continuing Education and Research Committee 1988 –1990, Saudi Pharmaceutical Society: Gained ACPE Approval for theSociety CE Program.

➢ Consultant and Member of Scientific Committee 1988 - 1990 Pan Arab Societyof Anesthesia and Critical Care

➢ Member of the Scientific Committee for Pharmaceutical Use and DrugEvaluation: 1984-1991, Ministry of Health, Riyadh, Saudi Arabia

➢ Member of the Central Committee for Pharmaceutical Services 1986 - 1990Ministry of Health, Riyadh, Saudi Arabia

➢ Participate in setting the standards of pharmacy practice in the Kingdom, aswell as development of a system for ADR reporting to the Ministry of Health

1985-1990

➢ Vice Chairman, Pharmacy and Therapeutic Committee 1985 - 1996 KingKhalid and King Abdulaziz University Hospitals ,Kind Saud University,Riyadh, Saudi Arabia

➢ Associate Director of Pharmacy Services March 1983 - 1985 Kind Khalid UniversityHospital Riyadh, Saudi Arabia

➢ Research Associate (Cardiac Surgery) Aug. 1981-Feb. 1983 United Hospitals, St.Paul, Minnesota, USAo Engaged in the development of studies protocols, supervision of all the

studies and carrying the statistical analysis as well as papers writing.

➢ Clinical Assistant Professor Aug. 1981 - Feb. 1983 College of PharmacyUniversity of Minnesota, Minneapolis, Minnesota, USA. Taught Pharm.D.Students clinical toxicology, and supervised the clinical clerkship at UnitedHospitals.

Awards

➢ Distinguished Leadership Award Jan. 1997, American BibliographicAssociation, USA

➢ Research Scientist, Toxicology, December 1990, University of Ghent, Belgium

Areas of Interest:

➢ Clinical Pharmacy Practice

➢ Critical Care Medicine

➢ Clinical Toxicology

➢ Clinical Pharmacokinetics

➢ Quality Management, and development of human resources

➢ Regulatory Affairs (Pharmaceuticals registrations laws)

➢ Pharmaceutical Industry planning

➢ Pharmacy Administration

Teaching Experience

➢ Clinical Instructor, College of Pharmacy, King Saud University, Riyadh,

Saudi Arabia. Teaching Pharmacy Students, Pharmacotheraputics andclerkship.

➢ Instructor, College of Allied Health, King Saud University, Riyadh, SaudiArabia. Teaching Quality Management course and tutorial 1995-2000

➢ Supervising and teaching Residency program 1984-1992 Critical CareMedicine, Toxicology, and Pharmacy Administration.

Teaching Residency Training Program in Anesthesia (Arab Board). ➢Antimicrobial Agents prescribing and Monitoring. 1995-1997

➢ Teaching pharmacy students Hospital Pharmacy and Pharmacy Administration,College of Pharmacy, King Saud University 1983-1992

➢ Clinical Assistant Professor, Teaching Pharm.D. students ClinicalPharmacy Activities, Clinical Clerkship, University of Minnesota,Minneapolis, USA 1980-1983

➢ Supervising Ph.D. students (Social and Administrative Pharmacy, ClinicalScientist program) research projects. College of Pharmacy University ofMinnesota, 1980-83

Research Experience

☒ Research related to setting the Standards of the Military Uniforms, and toevaluate the benefit and the specifications of the Uniforms. Also thespecifications of the NBC suits. (As consultant to the Ministry of Defenseand Aviation) 2000

☒ Gulf War Syndrome Study, assess the potential of the exposure of the SaudiTroops to the causes of the GW Syndrome. (As consultant to the Ministry ofDefense and Aviation)

☒ Impact of Exposure to Depleted Uranium Shell on the Saudi Troops duringthe Gulf war (Study conducted in 2001-2003) (As consultant to the Ministryof Defense and Aviation)

☒ Research Associate of the Cardiac Surgical Associates P.A. Mainresponsibilities were development of research protocols, data collection,data analysis and manuscript writing. Coordinated several researchprojects with Pharmaceutical companies and carried out several projects.The research projects carried out involved Cardioplegia, Pharmacokinetics,and effect of Cardiopulmonary bypass surgery (CPBS) on different drugs.

☒ As preceptor for community Medicine research projects, college ofMedicine, Kind Saud University, I have supervised a number ofprospective and retrospective research projects.

☒ Clinical Coordinator for more than 100 clinical research projects over thepast 13 years in Saudi Arabia, most of which were new Pharmaceuticals, inPhase II and III of their development. Some of these products are:

* Omeprazol (Phase II, and III)

* Voltarein Emulgel * Voltarein Inj. (for pain control post surgery)

* Noducromyl Sodium * Ceftazoxim * Tilcotel * Emla (Local Anesthetic) * Benazepril * Budinoside Inhaler and Nebulizing Solution

* Asterionam * Pravastatin (for familial hyperlipdemia)

Ibopamine ** Simvastatin * Dermacure (a new preparation for Deep Skin Ulcers)

* Immunoglobulins for threaten abortion

* 35 Bioequivalence Studies

* And many others.

Pharmaceutical Industrie Experience

1. Carrying feasibility study for I.V. Solution factory in Saudi Arabia, in collaborationwith Baxter Company USA 2000

2. Planning and gaining acceptance for International association with Eli Lilly indeveloping Biotechnology manufacturing facility in Saudi Arabia, Al-Ali Group Al-Ahsaa 1998

3. Planning for an I.V. manufacturing facility, Abdullah Fouad Group 1995

4. Consultant to development of IV Solution factory,Al-Hammad Group, Riyadh, 1994

Presentations

1. A. Saddique, “Future of Clinical Pharmacy Practice in Saudi Arabia”, SaudiPharmaceutical Society meeting, King Khalid Eye Specialist Hospital, September2015

2. A. Saddique, "Perspectives in Pharmacy Practice: Where Do We Stand?", SaudiPharmaceutical Society meeting, Hafr Albaten, eastern Province Dec. 2011

3. Impact of Financial Crisis on Healthcare Delivery. Arado Meeting, SharamAl-Shaikh, Egypt Dec. 13th -15 2009

4. Impact of Globalization on Healthcare,7th Arab Conference “New Trends inHospital Administration” “Performance improvement and cost containment in lightof current national &International Changes” Arado Meeting, Cairo Egypt Dec. 14th

2008

5. Application of Six Sigma in Healthcare, Review and Cast study, The QualityManagement In Healthcare Forum, Muscat, Oman 19th -20th Jan 2008

6. Healthcare Transformation and Its impact on Quality, The Quality Management InHealthcare Forum, Muscat, Oman 19th -20th Jan 2008

7. Principles of Performance Improvement, The Quality Management In HealthcareForum, Muscat, Oman 19th -20th Jan 2008

8. Building Core IT System for the Insurance Supervision Directorate in the Kingdomof Saudi Arabia, presented to Boos Allen Consulting Group, and SAMA Group.Four Seasons Hotel, Riyadh, October 2007

9. Application of Six Sigma in Education, Al-Zaytonah University, Amman JordanJuly 2006

10. Application of Six Sigma in Pharmaceutical Industry, Healthcare Quality Forum,Ammanm Jordan April 17th - 21st 2006

11. Six Sigma in Healthcare, Quality Management Meeting, Jeddah, March 2006

12. Pharmacology and Clinical Applications of Sevoflurane, Al-Mashoura Group,June 2005

13. Quality Management in Emergency Department, Emergency Medicine annualmeeting, April 2004.

14. Quality in Healthcare Assessment, Saudi Healthcare Economics: Present andFuture, Minstry of Defense and Aviation Conference, Dahrahn , Jan 13th-14th 2003

15. Strategies of Healthcare Management, Saudi Healthcare Economics: Present andFuture Minstry of Defense and Aviation Conference, Dahrahn , Jan 13th-14th 2003

16. Training Program On Protection Againest Weapons of Mass Destruction, Twoweeks program, Professional Intitute for Training, June 2003

17. Intesive Course in Healthcare Quality Management, Riyadh Chamber ofCommerce, Quality Management Diploma, in collaboration with AdministrationInstitute, Riyadh June 2003

18. Depleted Uranium, The Silver Bullet "The Truth", The 3rd GCC Conference ofMilitary Medicine and protection against weapons of Mass destruction. Qatar, Oct.20-23rd 2002

19. Transdermal Contraceptives, The first Conference on OB-Gyn, King SaudHospital, Unaizah Qassim, Oct. 2002

20. Medications Error, Patients Saftey conference, Social Insurance Hospital, Riyadh,Oct. 2002

21. Strategic Management Process of Healthcare Organizations, QIMS meeting,Beirut, Lebanon May 17-19, 2001

22. Investing in Biotechnology, 1st PCR meeting, Marriot Hotel, Eastern provience,Saudi Arabia

23. Reengineering Healthcare, Riyadh Quality Management Network, March 5th 2000,and National Guard “Quality Day” May 2000.

24. Rationalization of Drug prescribing, Government of Oman, as WHO-EMROconsultant, Nov. 7th, 1999

25. Development of Generics Strategy, Government of Oman, as WHO-EMROconsultant, Nov. 7th, 1999

26. Development of Antibiotics prescribing Policy to assure rational prescribing,Government of Oman, as WHO-EMRO consultant, Nov. 7th, 1999

27. Drug Use Studies using Indicators, Government of Oman, as WHO-EMROconsultant, Nov. 7th, 1999

28. Hospital Pharmacists, WHO/EMRO Expert meeting for the development ofPharmacy Text Book, May 26-29, 1999, Cairo, Egypt

29. Mobilizing Staff and Management to fulfill the requirement of your QualityManagement Program, Quality Concepts meeting, King Fahad Hospital , Hafouf,May 19th 1999

30. Dynamics of Healthcare and its management Systems, King Fahad Hospital ,Hafouf, May 19th 1999

31. The basic concepts of TQM, Prince Salman Hospital, Riyadh Health DirectorateSeminar on Quality, May 8th, 1999*

32. Antibiotics Prescribing, Monitoring and Patients Outcome, King Fahad HospitalHafouf, Sep. 16th, 1998 *

33. The Dynamics of Quality in Healthcare, Hospitals management seminar, KingKhalid Eye Specialist Hospital, May 16th, 1998.*

34. Quality Improvement Systems’ Management, Riyadh Quality ManagementNetwork meeting, King Faisal Specialists Hospital, Nov. 10th 1997. *

35. Pros and Cons of KAIZEN, the Japanese Management System. ThirdAdministrative Symposium Organized by the Medical Services of the Armed Forces,Al-Hada Military Hospital. Oct. 12th - 15th 1997 *

36. Development of a Contingency Plan for Health Care Organizations. ThirdAdministrative Symposium Organized by the Medical Services of the Armed Forces,Al-Hada Military Hospital. Oct. 12-15th 1997 *

37. New Pharmacotherapeutic approach to the management of diseases using AdverseDrug Reactions. 10 Th. Kuwaiti Medical Association meeting, Kuwait, Dec. 1996

38. Management of Poisoning, Ten years Experience at King Khalid UniversityHospital, 10 Th. Kuwaiti Medical Association meeting, Kuwait, Dec. 1996

39. Rationalization of Antibiotics prescribing, King Khalid University HospitalExperience. 10 Th. Mediterranean Congress of Chemotherapy. Antalya, TurkeyOctober 1996

40. Computerization of Pharmacy and other Hospital services in Saudi Arabia and

Kuwait. 10 Th. Mediterranean Congress of Chemotherapy. Antalya, Turkey October1996

41. Pharmacies a profession in transition, current and future practice trends, KuwaitPharmaceutical Society "free lecture.” Dec. 1996

42. Motivating staff to fulfill the needs of your Quality Improvement program, KuwaitPharmaceutical Society "free lecture.” Dec. 1996

43. Total Quality Management Application in healthcare. Symposium on New Trendsin Pharmacy Practice. Muscat, Oman, May 1996*

44. Total Parenteral Nutrition Clinical Implications. Symposium on New Trends inPharmacy Practice. Muscat, Oman, May 1996*

45. Unit Dose System, How essential? . Symposium on New Trends in PharmacyPractice. Muscat, Oman, May 1996*

46. Application of Continuous Quality Improvement (CQI), as a problem solving toolin Pharmacy Practice. Riyadh Total Quality Management Network, Riyadh, April1996.

47. Facilitating Quality Improvement by Optimal Use of Information SystemTechnology. The fourth Kuwait Pharmaceutical Association Conference ForComputerization Of Pharmaceutical Services, March 4-6, 1996 *

48. Computerization of Drug Information "How Essential ", The fourth KuwaitPharmaceutical Association Conference For Computerization Of PharmaceuticalServices, March 4-6, 1996 *

49. Application of Computer Technology in Drug Dispensing. The fourth KuwaitPharmaceutical Association Conference For Computerization Of PharmaceuticalServices, March 4-6, 1996 *

50. "Knowledge Based Systems" Their Impact on National Health InformationSystems. The fourth Kuwait Pharmaceutical Association Conference ForComputerization Of Pharmaceutical Services, March 4-6, 1996 *

51. Antibiotics prescribing, Monitoring and Patient’s Outcome. KuwaitPharmaceutical Association "Free Lecture, Continuing Education", March 1996 *

52. Total Quality Management, a series of lectures and round table discussion, KuwaitOil Company, Al- Ahmadi Hospital, March, 1995 *

53. Total Quality Management" , Egyptian Hospital Pharmacy meeting, Cairo, March,1994*

54. Essential Drugs Prescribing and Teaching in the Colleges of Pharmacy andMedicine Curricula, WHO meeting on Essential Drugs, Bahrain, April, 1994*

55. "Rationalization of Antibiotic Prescribing, Saudi Experience", Arabian Society of Clinical Microbiology and Infectious Diseases Meeting, Cairo, 1992*

56. "Quality of Life, Pharmacist’s role", Japanese Pharmaceutical Associationmeeting. Hiroshima; August, 1992 *

57. "Generics, Criteria for Selection", Japanese Pharmaceutical Associationmeeting; Hiroshima; August, 1992 *

58. "Management of Chemical Warfare Agents exposure", College of Medicine,special seminar during the Gulf war Jan. 1991

59. "Management of Chemical Warfare Causalities", A series of lectures to theMedical staff as 5 Symposia were organized during the Gulf Ware, 15 lectures Jan -Feb. 1991

60. Television Series on Chemical warfare Agents, Public awareness Jan-Feb. 1991.

61. "Bioequivalence of Drugs, A Second Look", NODCAR, seminar on qualityassurance of Pharmaceutical preparations, Cairo, Egypt, Oct. 1990 *

62. "Development of Clinical Pharmacy Services in KKUH, Seven years experience",Kuwait Pharmaceutical association Meeting, Kuwait, Feb. 1990 *

63. "History of Pharmacy in Saudi Arabia", First Annual Meeting of the Saudi Pharmaceutical Society, Riyadh, Saudi Arabia, Nov. 1986 *

64. "Treatment of AIDS", Seminar on HIV infection and AIDS, Riyadh, Saudi Arabia,Feb. 1986

65. "Selection of Drugs for the Gulf Area", Fourth Drug Symposium, Riyadh, SaudiArabia, Feb. 1986 *

66. "Pharmacy in Saudi Arabia, New Development", University of Hiroshima, Japan,Nov. 1988 *

67. "Total Parenteral Nutrition: Clinical Importance", New development in Hospital Pharmacy Symposium, Hafouf, Saudi Arabia, Oct. 1988

68. "Understanding Clinical Pharmacy", Presented in the Drug Symposium, Madina,Saudi Arabia, Aug. 1988

69. "Pharmacokinetics of Anesthetic Agents; Clinical Considerations,” presented inthe Second Anesthesia Congress for Pan Arab Society of Anesthesia and CriticalCare, Cairo, Egypt, Dec. 1987.

70. "Clinical Pharmacy in Critical Care: Presented in Critical Care Opinion LeadersProgram, Indianapolis, Indiana, and USA.

71. "Drug Registration In Saudi Arabia,” Presented to the American PharmaceuticalAssociation meeting, Rome, Italy, May 1986.

72. "The Public, The Pharmacist and Self Medications,” presented at the third drugSymposium Riyadh, Saudi Arabia, 1984.

73. "Implementation of clinical Pharmacokinetics Service,” presented at the clinicalPharmacy symposium, Riyadh, Saudi Arabia, 1984.

74. "Basics in the Management of Poisoning,” Clinical Pharmacology and Toxicologysymposium, Joint Board of Postgraduate Education, Riyadh, Saudi Arabia, 1983.

75. "The role of Clinical Pharmacokinetics Service in Maximizing Drug Therapy,”Postgraduate Education Seminar, Riyadh, Saudi Arabia, 1983.

76. "Thallium Poisoning,” Clinical Toxicology group at Hennipin County MedicalCenter, Minneapolis, Minnesota, 1981.

77. "Clinical Pharmacy,” College of Pharmacy Faculty, Riyadh, Saudi Arabia, 1981.

78. "Acute vs. Chronic Salicylate Toxicity- Effect of Prothrombin Time", Collegeof Pharmacy Clinical Faculty and Students, University of Minnesota,Minneapolis, Minnesota 1980.

79. "Inhibitor of the Renin Angiotensin System" College of Pharmacy, ClinicalFaculty, Minneapolis, Minnesota, 1979.

80. The Puzzle of Schizophrenia, Medical Staff of the Community University HealthCenter, Minneapolis, Minnesota, 1979.

81. Procarbazine and Hodgkin’s Disease", Oncology Nursing Service, University of Minnesota, Masonic Hospital, Minneapolis, Minnesota, 1979

* By Invitation

Consultancy Experience

➢ Administration Consultant, King Khalid Eye Specialist Hospital June 2014-May 2015

➢ Consultant to Sultan Abdulaziz Al-Mousa Group, Re-engineering of theGroup, Developed the organization structure, Human Resources Manual,Financial Manual and the the strategic plan for the group.

➢ NBC Consultant, Medical Services of the Ministry of Defense and Aviation, Since1999-2009.

o As a consultant I have completed the following tasks:

▪ Depleted Uranium Report

▪ Gulf War Syndrome Report

▪ Management of Asbestos in Military installations, anddeveloped a program for Asbestos removal from old housesand compounds at military installations.

▪ Anthrax Vaccine, a report and review of literature

▪ Development of the NBC plant for the Medical Services of theMinistry of Defense and Aviation.

▪ Carried out Study on the Military Uniforms, the study wascompleted and presented.

▪ Completed a Study on Gulf War Syndrome among the SaudiTroops participated in the Gulf War,

▪ Ongoing Study on the health Effects of Depleted Uraniumamong the Saudi Troops.

➢ WHO-EMRO STC, Oct. 1999-2002, responsible for developing drugutilization policies for under-developed countries to optimize medicationsuse and prescribing.

➢ Quality Management consultant, Riyadh Health Directorate, 1998- 2000

➢ VIP Consultant, Total Quality Management, Kuwait Oil Company, AhmadiHospital, March 1995 & 1996.

➢ VIP Consultant, Pharmaceutical Services, Kuwait Oil Company, Ahmadi Hospital,March 1995. Optimized drug dispensing and implemented drug use evaluationprogram.

➢ VIP Consultant, Pharmaceutical Services, Kuwait Oil Company, Ahmadi Hospital,March 1996, Follow-up on optimization of drug dispensing, Started a DrugInformation Center and enforced Drug Use Evaluation.

➢ Technical Consultant to PDC Pharmaceuticals, Milwaukee, Wisconsin, USA ,1995- 2002

➢ Consultant to the Ministry of Health " see under professional experience,” 1983-1996.

➢ Consultant to the US Army during the Gulf War 1990 on weapons of massdestruction. Co-trainer to the troops on Protection against weapons of massdestruction.

Publications

A. Books:

1. Chemical, Biological, And Nuclear, Warfare Preparedness Plan, prepared for theMinistry of Defense and Aviation, 2003

2. Saddique, Editor "Work Practice Guidelines, for personnel dealing with HazardousDrugs", Prepared by Wafaa Shwaiky, Published by Faulding , DBL Co., Jan. 1997

3. Saddique " Continuous Quality Improvement, A model for Health Care" King SaudUniversity Press, 1995, ISBN 9660-27-665-4

4. Saddique , Pharm.D., Adam Cafege, Pharm.D., "Guide to the Management ofPoisoning" , First and Second Edition , King Saud University Press, 1996, ISBN9660-27-665-4

5. Saddique,& Ad Hoc Committee, Ministry of Health, "Management of Chemicalwarfare Casualties" Dec. 1990

6. M.Seraj, FFRCSI, A.Saddique, Pharm.D., " Brief Notes and Guidelines on Toxic

Chemicals and their effects, Air Raids and Siren Instructions", Safir Press, Riyadh,Saudi Arabia, 1990

7. Saddique, Pharm.D. and the Scientific Committee of the Ministry of Health, " DrugDirectory" for the Ministry of Health 2nd and 3rd Edition, Saudi Arabian PrintingCompany, Ltd. Riyadh, Saudi Arabia, , 1989. 1896

B. Papers Published:

1. A. Saddique, Development of Clinical Pharmacy at King Khalid University Hospitaland its impact on the quality of healthcare provided, Saudi Pharmaceutical SocietyJournal Saudi Pharmaceutical Journal (2012) 20, 273–277

2. Poisoning in Saudi Arabia, Ten Years Experience, Annals of Saudi Medicine, Vol 21,No 1,2January/March 2001

3. Quality Management, Helps leaders in implementing decentralized managementsystem. Quality Management Newsletter, Ministry of Health, Vol. 1 Rabi Al-Awwal1423 pp 4-5 (Arabic)

4. A.A.El-Dawlatly, MD, H. Bakhamees, DA; S.Al-Majid, FRCP, A.Al-SaddiquePharm.D., " Physostigmine Reversal of Carbon Monoxide Coma.” Annals of SaudiMedicine, Vol 17, No 3, (334-336), 1997

5. A. Saddique; "Computerization of Drug Information-How Essential?” ThePharmacist, Journal of the Kuwait Pharmaceutical Association, Vol. 14, No.2, (4-11),1997

6. Naguib, Mohammed, Bakry, Abdulkarim, Abdulaziz Saddique et al, Prophylacticantiemetic therapy with ondansetron, tropisctron, granisetron and metoclopramidein patients undergoing laparoscopic cholecystectomy: A randomized, double blindcomparison with placebo. Canadian Journal of Anesthesia, Vol.43,3,226-231,1996

7. D.F.Fayed, N.S. Dahmash, A.A. Saddique, A.M. Shibl, "Evaluation Of AzteronamIn The Treatment Of Serious Gram-negative Infections In A University Hospital InSaudi Arabia" Journal of Chemotherapy, Vol. 4, No.3, (167-170)- 1992.

8. Al-Momen Abdulkareem, Al-Meshari Abdulaziz, Al-Nuaim Lulu,Saddique Abdulaziz, Abotalib Zainab, Kashoggi Tariq, Abbas Munir. Intravenous iron sucrose complex in the treatment of iron deficiencyanemia during pregnancy. Eur J Obst & Gyn Reprod Biology1996;69:121-124.

9. A.Saddique, Pharm.D., "Rationalization of Antibiotics prescribing" Health ServicesJournal of the Eastern Mediterranean Region, WHO, Vol. 6,2, 11-16, 1992.

10. A.K. Al-Momen, A. Saddique et al, "Therapeutic Effect of human Erythropoietin(r-HuEPO) on Sickle Cell Disease,” Annals of Saudi Medicine Vol. 10 No.6: 507-510,Jan. 1992.

11. A.Chana, M.Seraj, A.Saddique, A.Samarkandi, "Dantrolene is Effective in

Heat Stroke", Critical Care Medicine Vol. 18, No.3, 290-292, March 1990.

12. S.R. Al-Balla, A.Al-Naser, H. Al-arfaj, Z.Hammoh, S. Al-Sugair,A.Saddique, "Randomized Double Blind Short-Term Trial of Tenoxicamversus Piroxicam in Osteoarthritis of the Knee,” Current TherapeuticResearch Vol. 47, No.3: 591-596, March 1990.

13. S.S.Al-Harthi, O.Karrar, S.A. Al-Mushhadani, A.Saddique, "Metabolite andHormonal Profiles in Heat Stroke Patients at Makkah Pilgrimage", Journal ofInternal Medicine, Jan. 8,1990

14. Y.Al-Eissa, H.Bahakim, A.Mahdi, A.Saddique, K.Amoh, "Accidental CastorOil Seed Poisoning In Saudi Children,” Annals of Saudi Medicine, Vol. 9No.6: 609-611, Nov. 1989.

15. M.M.El-Sheikh, M.R.Dakkak, A.Saddique, "The Effect of Permixon on AndrogenReceptors" Acta Obstet Gynecol Scandinavia, Vol. 67:397-399, 1988.

16. A.Saddique, C.Peterson, "Thallium Poisoning, A.Review,” Vet. and HumanToxicology, Vol. 25, No.1: 16-22, 1983

PAPERS PRESENTED IN INTERNATIONAL CONFERENCES

1. A. Saddique "Management of Poisoning, Ten years Experience at King Khalid

University Hospital", 10 Th. Kuwaiti Medical Association meeting, Kuwait, Dec.1996

2. A. Saddique, "New Pharmacotherapeutic approach to the management of diseasesusing Adverse Drug Reactions". 10 Th. Kuwaiti Medical Association meeting,Kuwait, Dec. 1996

3. A.K.Al-Momen, A.Saddique, et al, "Danazol Therapy in Thrombotic StatesAssociated with Severely Impaired Fibrinoletic Activity,” presented at the 10thInternational Congress of Fibrinolysis, Indianapolis, Aug. 1990.

4. A.K. Al-Momen, S.O. Huraib, A. Saddique, M.A. Gader, "Treatment ofRecombinant Human Erythropoetin (rh-EPO)- Induced Thrombosis withDanazol", presented at the American Society of Hematology meeting Aug. 1988.

5. Al-Momen AK, Shamena AR, Saddique AA, Gader AMA. Danazoltherapy in thrombotic states associated with several impairedfibrinolytic activity. 10th International Congress on Fibrinolysis. Fibrinolysis 1990;4(3):115, Abstr #294.

6. Al-Momen AK, Alballa S, Gader AMA, Saddique AA. Hypofibrinolysis in Behcet’s disease: response to danazol therapy. 2nd

Mediterranean Congress of Angiology, Antalya, Turkey. 16-21September 1990. MBC-206.

7. Al-Momen AK, Saddique AA, El-Hazmi MA, Harakati MS, Warsy A. Therapeutic effect of human erythropoietin (r-HuEPO) on sicle celldisease. 5th meeting of the Mediterranean Blood Club, Antalya,Turkey. 21-24 September, MBC-205.

8. Al-Momen AK, Alballa S, Gader AMA, Saddique AA. Hypofibrinolysis in Behcet’s Disease: Response to Danazol therapy. Symposium on “Uveitis: Basic Principles and clinical Practice”. College of Medicine, King Saud University, 23-24 September 1990.

9. .Al-Momen AK, Huraib SO, Al-Mitwalli AH, Al-Wakeel J, Abu-AishaH and Saddique A. Enhancement of 4-HuEPO effects by ironsaccharate in hemodialysis patients. 28th Annual Meeting of AmericanSociety of Nephrology. 5-8 November 1995.

10. Saddique; "Rationalization of Antibiotics prescribing, King Khalid

University Hospital Experience.” Proceeding of the 10 Th.Mediterranean Congress of Chemotherapy. Antalya, Turkey October1996

11. A. Saddique, O. Tulesius, A & R Dobardzic, and S.F. Al- Ali, "Computerization ofPharmacy and other Hospital services in Saudi Arabia and Kuwait.” Proceeding ofthe 10 Th. Mediterranean Congress of Chemotherapy. Antalya, Turkey October1996

12. Management of Poisoning, Ten years Experience at King Khalid UniversityHospital, Proceeding of the 10th Kuwaiti Medical Association meeting, Kuwait, Dec.1996

13. New Pharmacotherapeutic approach to the management of diseases usingAdverse Drug Reactions. Proceeding of the 10 Th. Kuwaiti MedicalAssociation meeting, Kuwait, Dec. 1996

14. Al-Momen AK, Saddique AA, El-Hazmi MA, Harakati MS, WarsyA. Therapeutic effect of human erythropoietin (r-HuEPO) on sicle celldisease. 5th meeting of the Mediterranean Blood Club, Antalya,Turkey. 21-24 September, MBC-205.

15. Al-Momen AK, Alballa S, Gader AMA, Saddique AA. Hypofibrinolysis in Behcet’s Disease: Response to Danazol therapy. Symposium on “Uveitis: Basic Principles and clinical Practice”. College of Medicine, King Saud University, 23-24 September 1990.

16. Al-Momen AK, Huraib SO, Al-Mitwalli AH, Al-Wakeel J, Abu-Aisha Hand Saddique A. Enhancement of 4-HuEPO effects by iron saccharate inhemodialysis patients. 28th Annual Meeting of American Society ofNephrology. 5-8 November 1995.

17. Al-Momen AK, Shamena AR, Saddique AA, Gader AMA. Danazoltherapy in thrombotic states associated with several impairedfibrinolytic activity. 10th International Congress on Fibrinolysis. Fibrinolysis 1990;4(3):115, Abstr #294.

18. Al-Momen AK, Alballa S, Gader AMA, Saddique AA. Hypofibrinolysis in Behcet’s disease: response to danazol therapy. 2nd

Mediterranean Congress of Angiology, Antalya, Turkey. 16-21September 1990. MBC-206.

19. A.K.Al-Momen, A.Saddique, et al, "Danazol Therapy in Thrombotic StatesAssociated with Severely Impaired Fibrinoletic Activity,” presented at theAmerican Society of Hematology meeting Aug. 1989.

20. G.Solis, D.North, A.Hall, A. Saddique, "Peritonitis in C.A.P.D.; Standardization ofEmpiric Antibiotic Therapy,” presented at the ASHP midyear Clinical meeting,Dallas Texas, 1989.

21. A. Saddique, Pharm.D., "Selection of Drugs for the Gulf Area,” Proceedings of thefourth Drug Symposium in Saudi Arabia, College of Pharmacy, Jan. 1989.

22. A.Saddique, Pharm.D., "The public the Pharmacist and Self-Medications",Proceedings of the Third Drug Symposium in Saudi Arabia on Role of Pharmacy inHealth Care, 11-20, 1988.

23. K.V. Arom, A. Saddique , D.M.Angaran, et al, "First Clinical trial of L-GlutamateCardioplegia" presented at Samson Thoracic Surgical Society meeting, N.Carolina,Feb. 1982.

Courses Prepared delivered or planned:

1. Preparation for CPHQ certification course, 10 days 2014-2015

2. Total Quality Management, King Khalid Eye Specialist HospitalMay 2014

3. Operation Management, King Khalid Eye Specialist Hospital, July2014

4. Orientation to Six Sigma, 5 days course

5. Strategic Planning, Oman May 2013, 3 days course

6. Train the Trainer, Oman March 2010

7. 9 on-going Pharmacy Education programs in collaboration with theAl-Habib Medical Center, Riyadh 2001- Present

8. Training Program On Protection Againest Weapons of MassDestruction, Two weeks program, Professional Institute forTraining, June 2003,2005,2008,2009

9. Clinical Toxicology, Basic Training Course two weeks program.Accredeted for 27 CME hours. By the Saudi Health Counsel, Oct.2004

10. Application of Six Sigma in Healthcare

i. Riyadh

ii. Jeddah

iii. Lebanon (March 2003)

iiii. Bahrain (April 2003)

v. Dubai (May 2003)

11. Kaizen the Japanese Management System (three days)

12. Orientation and training for Quality facilitators (22 Days at 2hours per day)

13. The Ultimate Quality Improvement Program, Kaizen, LeanProcessing and Six Sigma, Riyadh, Al-Habib Medical Center 2002.

Symposia Precipitated As Chairman and Moderator

➢ Chairman, Saudi Healthcare Economics Symposium: Present and Future Jan13th-14th 2003,

➢ Symposiam Chairman and Key Note Speaker, HealthCare Economics, Organizedby Medical Services of the Ministry of Defense and Aviation, Jan 2004

➢ "New trend in the Management of Ulcer" lectures and round tablediscussion, Al-Khozama Hotel, Riyadh, Saudi Arabia, 1991

➢ "Management of Nosocomial Infection" Lectures and round tableDiscussion, Al-Khozama Hotel, Riyadh, Saudi Arabia, Nov. 1989

➢ Third Saudi French Medical Symposium, Second Session on Nutrition, Intercontinental Hotel, Riyadh, Saudi Arabia, Feb. 1989.

➢ "Third Generation Cephalosporins Place in Therapy", Lectures and round tablediscussion., Khozama Hotel, 1989

➢ Second Saudi French Medical Symposium, First session on Hepatitis Vaccinedevelopment, Intercontinental Hotel, Riyadh, Saudi Arabia, Feb. 1986.

➢ "Safety of Blood Products,” Lectures and round table discussion,Marriott Hotel, Riyadh, Saudi Arabia, 1986.

➢ "Management of Serious Gram Negative Infection" Lecture and round tablediscussion, Marriott Hotel, Riyadh, Saudi Arabia, 1985

Other Activities:

➢ External Examiner, Prince Naif University, Master Degree on

Application of Total Quality Management in Passport Office, Riyadh

➢ Business Consultant to Al-Ali Group, Al-Ahsaa 2001

➢ Joint Consultant Abdullah Fouad Group, Dammam 2000

➢ New Projects Development Consultant, Al-Ajo group 1999

➢ Healthcare Projects Consultant, Gulf Consulting company, Riyadh1998-1999

➢ PDC Consultant for new business development, 1997-1999 WisconsinUSA

Professional membership

1. National Association of Healthcare Quality, Since 2000

2. Saudi Pharmaceutical Society (Honorary) Since 1988

3. American Society of Quality, Since 2000

4. Pan Arab Society for Anesthesia and Critical Care.

5. American Society of Hospital Pharmacists.

6. Riyadh, Healthcare Quality Management Network.

7. Kuwait Pharmaceutical Association (Honorary) Since 1996

8. Saudi Arabian Quality Council, of the International chapter of ASQ 20.9.2000